Figure 6
Figure 6. In vitro and in vivo targeting of scFvSCE5 in mouse platelets. (A) Flow cytometric detection of scFv-CD39 constructs using an Alexa Fluor-488–coupled anti–Penta-His antibody that binds to the constructs’ 6xHis-tags. Representative histograms showing binding of targeted or nontargeted CD39 constructs as assessed by a secondary anti–Penta-His Alexa Fluor-488 antibody. Nonactivated and activated platelets were differentiated by gating with a PE-labeled anti–P-selectin antibody. (B) Intravital microscopy of delayed binding of scFvSCE5 to adhering platelets. Representative images of the formation of a platelet layer induced by ferric chloride injury in the mesenteric artery. ScFvSCE5 binding was detected by an anti–Penta-His Alexa Fluor-488 antibody. Time point 0 depicts time after 4 minutes of ferric chloride–induced injury and 1 minute after flushing with saline when platelets began to attach to the injured site.

In vitro and in vivo targeting of scFvSCE5 in mouse platelets. (A) Flow cytometric detection of scFv-CD39 constructs using an Alexa Fluor-488–coupled anti–Penta-His antibody that binds to the constructs’ 6xHis-tags. Representative histograms showing binding of targeted or nontargeted CD39 constructs as assessed by a secondary anti–Penta-His Alexa Fluor-488 antibody. Nonactivated and activated platelets were differentiated by gating with a PE-labeled anti–P-selectin antibody. (B) Intravital microscopy of delayed binding of scFvSCE5 to adhering platelets. Representative images of the formation of a platelet layer induced by ferric chloride injury in the mesenteric artery. ScFvSCE5 binding was detected by an anti–Penta-His Alexa Fluor-488 antibody. Time point 0 depicts time after 4 minutes of ferric chloride–induced injury and 1 minute after flushing with saline when platelets began to attach to the injured site.

Close Modal

or Create an Account

Close Modal
Close Modal